Drug – bio-affecting and body treating compositions – Enzyme or coenzyme containing – Hydrolases
Patent
1996-07-19
1999-02-23
Naff, David M.
Drug, bio-affecting and body treating compositions
Enzyme or coenzyme containing
Hydrolases
424 941, 514 2, 514 21, 435183, 435195, 435198, 4352521, 4352525, 4352527, 4352529, 4352531, 4352532, 4352534, A61K 3846, C12N 920
Patent
active
058740791
ABSTRACT:
Disclosed herein are methods for killing Gram-positive bacterial infections in animals comprising exposing the bacteria to Gram-positive bactericidal-effective amounts of Type II phospholipase A2. The Type II phospholipase A2 can be isolated from mammalian species including humans, cows, rabbits, rats, mice, cats, and dogs. Type II phospholipase A2 is effective in treating infections in mammals, including humans, caused by gram-positive bacteria such as Staphylococcus aureus. Also disclosed are pharmaceutical formulations for use in the methods.
REFERENCES:
patent: 4209508 (1980-06-01), Mitsui et al.
patent: 4822608 (1989-04-01), Benton et al.
patent: 4883673 (1989-11-01), Gonzales
patent: 4929445 (1990-05-01), Vandenbergh et al.
patent: 5019508 (1991-05-01), Johnson et al.
patent: 5116615 (1992-05-01), Gokcen et al.
patent: 5338682 (1994-08-01), Sasaki et al.
patent: 5338724 (1994-08-01), Gabay et al.
patent: 5447914 (1995-09-01), Travis et al.
patent: 5482723 (1996-01-01), Sasaki et al.
patent: 5504082 (1996-04-01), Kawakita et al.
Myrvik, Serum Bactericidins Active Against Gram-Positive Bacteria, Ann. New York Acad. Sci., 66:391-400, 1956.
Hay et al., Lipid Mediators, Ed. F. Cunningham, Academic press Inc., San Diego, CA, Chapter 5, pp. 122-123, 1994.
Inada, M. et al., J. Biol. Chem., 269(42):26338-26343, Oct. 21, 1994.
Sheagren, J., New Eng. J. Med., 310,:1368-1369, 1984.
Cohen, M.L., Trends in Microbiol., 2:422-425, 1994.
Wright, G.W. et al., J. Biol. Chem., 265(12):6675-6681, Apr. 25, 1990.
Weiss, J. et al., J. Biol. Chem., 269(42):26331-26337, Oct. 21, 1994.
Bomalaski, J.S. et al., J. Immunol., 146(11):3904-3910, Jun. 1, 1991.
Cirino, G. et al., J. Rheumatol., 21:824-9, 1994.
Santos, A.A. et al., Annals of Surgery, 219(2):183-192, 1994.
Snyder, D.W. et al., J. Pharm. and Exper. Therapeutics, 266(3):1147-1155, 1993.
MacPhee, M. et al., Cell, 81:957-966, Jun. 16, 1995.
Kramer, R.M. et al., J. Biol. Chem., 264(10):5768-5775, Apr. 5, 1989.
Weinrauch, Y. et al., J. Clin. Invest., 95:1916-1924, Apr. 1995.
Cirino, G. et al, J. Rheumatol., 21(5):824-829, 1994.
Harwig, S.S.L. et a., J. Clin. Invest., 95603-610, Feb. 1995.
Dennis, E.A., J. Biol. Chem., 269:10357-10360, 1994.
Elsbach Peter
Weinrauch Yvette
Weiss Jerrold
Kerr Janet M.
Naff David M.
New York University
LandOfFree
Method for killing gram positive bacteria with isolated type II does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method for killing gram positive bacteria with isolated type II , we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method for killing gram positive bacteria with isolated type II will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-304164